The Tet2-KO mice had a markedly reduced incidence of diabetes (median survival undefined) compared to WT recipients of NOD WT BM (median survival = 11 weeks) (p < 0.0001) (Fig. 3a). This evidence concerns the gene TET2 and diabetes mellitus.